GLP-1 medications work through several complementary mechanisms: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood sugar levels Suppressing glucagon release , thereby reducing hepatic glucose production Slowing gastric emptying , which prolongs satiety and reduces appetite Acting on appetite centres in the brain , leading to reduced caloric intake and weight loss Commonly prescribed GLP-1 receptor agonists available in the UK include semaglutide (Ozempic, Wegovy, Rybelsus [oral form]), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and exenatide (Byetta, Bydureon)
This means that the apps at each end can be different, as long as they use that same RCS protocol
Nausea peaks, food aversions develop (meat and coffee are common triggers), early satiety intensifies, and fatigue increases from the combination of medication adjustment and reduced calorie intake
Schedule a consultation today to begin your journey towards a more confident and beautiful you